REVIEW PAPER
Navigating the landscape of human papillomavirus-related anal cancer screening: a review for men who have sex with men
More details
Hide details
1
Faculty of Medical Sciences, Medical University of Silesia in Katowice, Poland
2
Department of Internal Medicine, Bonifraters Medical Center Ltd., Poland
3
Department of Internal Medicine, Medical Center in Łańcut Ltd., Poland
4
Department of Internal Medicine, Provincial Hospital in Poznań, Poland
Submission date: 2024-07-03
Final revision date: 2024-08-07
Acceptance date: 2024-08-13
Publication date: 2025-03-31
Corresponding author
Dominik Trojanowski
Faculty of Medical Sciences, Medical University of Silesia in Katowice, 15 Poniatowskiego Str., 40-055 Katowice
LW 2025;103(1):21-25
KEYWORDS
TOPICS
ABSTRACT
Introduction: Human papillomavirus (HPV) infection presents a significant global health concern, particularly due to its association with anal cancer, disproportionately affecting men who have sex with men (MSM). There is an urgent need for tailored screening strategies for this demographic. This review provides an overview of HPV-related anal cancer screening methods in MSM, highlighting their strengths, limitations, and future research directions. State of knowledge: Epidemiological studies have elucidated the prevalence of HPV-associated anal squamous intraepithelial lesions among MSM, underscoring the necessity for targeted screening. Various methods, including anal cytology, high-risk HPV (hrHPV) testing, and high-resolution anoscopy, have been proposed and evaluated. Despite challenges, tailored screening protocols have been developed to accommodate high-risk populations. Conclusions: Targeted screening strategies, especially for MSM living with HIV, are pivotal in mitigating the burden of HPV-related anal cancer. Expanding access to high-resolution anoscopy and addressing knowledge gaps are imperative. Further research into effective screening methods, including HPV-related biomarkers, is essential to enhance early detection and improve outcomes for at-risk MSM populations. This synthesis of evidence provides valuable insights for healthcare providers, policymakers, and stakeholders engaged in anal cancer prevention and control efforts.